# Mirum Pharmaceuticals, Inc. (MIRM) — capital_raise [announced]
Source: SEC API (secapi.ai) · situation sit_bbd9ff634111272e336f · retrieved 2026-08-12T06:58:54.112Z

## Overview
Mirum Pharmaceuticals is a leading rare disease company with approved products including LIVMARLI (maralixibat) for cholestatic liver diseases, CHOLBAM (cholic acid) for bile acid synthesis disorders, and CTEXLI (chenodiol) for cerebrotendinous xanthomatosis, along with a pipeline of investigational medicines in late-stage development.

Mirum Pharmaceuticals issued $690.0 million aggregate principal amount of 0.00% convertible senior notes due 2032. Concurrently, the company settled $237.2 million aggregate principal amount of 4.00% convertible senior notes due 2029, representing approximately 75% of the then-outstanding notes. The company reported unrestricted cash, cash equivalents, and investments of $561.3 million as of June 30, 2026, compared to $391.4 million as of December 31, 2025.

## Terms
- Deal value: $690.0M · Consideration: mixed

## Key dates
- Announced 2026-08-05 · Expiry 2032-12-31

## Timeline
- 2026-08-05 · 8-K (0001759425-26-000044): 8-K - Mirum Pharmaceuticals, Inc. — *Mirum Pharmaceuticals is a leading rare disease company with approved products including LIVMARLI (maralixibat) for cholestatic liver diseases, CHOLBAM (cholic acid) for bile acid synthesis disorders, and CTEXLI (chenodiol) for cerebrotendinous xanthomatosis, along with a pipeline of investigational medicines in late-stage development.* Mirum Pharmaceuticals issued $690.0 million aggregate principal amount of 0.00% convertible senior notes due 2032. Concurrently, the company settled $237.2 million aggregate principal amount of 4.00% convertible senior notes due 2029, representing approximately 75% of the then-outstanding notes. The company reported unrestricted cash, cash equivalents, and investments of $561.3 million as of June 30, 2026, compared to $391.4 million as of December 31, 2025.
  https://www.sec.gov/Archives/edgar/data/1759425/0001759425-26-000044.txt

## Citations
- 0001759425-26-000044 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000175942526000044